WASHINGTON, Dec. 13, 2017 — Continued Congressional support for traumatic brain injury treatment and diagnosis will enable further research, clinical innovations and focus on military readiness, said Navy Capt. (Dr.) Michael Colston, the Defense Department’s director of military health policy and oversight for the assistant secretary of defense for health affairs.
Colston appeared before the Senate Armed Forces Committee’s panel on personnel to update members on DoD’s work in the TBI arena for service members, veterans
“The department's approach to evaluation and treatment of TBI at the point of injury facilitates rapid identification and recovery, reducing the chance of another concussion before a service member's healed from a first,” he said.
DoD’s mandatory screening program for TBI also promotes early identification of service members with
“We know that after a brief period of rest it, [a person with a concussion] can begin a progressive return to activity,” Colston said.
Vast Majority Improve
“The vast majority of individuals who sustain a concussion improve clinically and don't have any sequelae [a condition that follows a previous disease or injury],” he noted, adding that on the other hand, doctors see patients who continue to suffer.
“In my practice as a psychiatrist, I've seen a number of TBI patients with co-morbidities such as adjustment disorders, pain, anxiety, depression, [post-traumatic stress disorder] and substance-use disorders. So in short, we find TBI is a protean disorder that can present with a wide range of cognitive, behavioral and physical deficits,” Colston said.
However, “We need to meet patients where they are on the road to recovery so DoD remains focused on hard problems around diagnostic clarification
“As we look to the future of TBI research, we appreciate that the human brain represents the most complex organization of living structures in all of biology,” Colston emphasized. “Our investments will pay returns.”
(Follow Terri Moon Cronk on Twitter: @MoonCronkDoD)
